Syntara Limited (SNT), formerly known as Pharmaxis Ltd, is a clinical-stage drug development company specialising in treatments for blood-related cancers. The company's drug discovery efforts are centred around its expertise in amine oxidase inhibitors, which play a key role in its research and development processes. Syntara is dedicated to advancing new therapies for these challenging conditions through its innovative approach to drug discovery.